Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Inorganic Biochemistry

• Publication date

  2012-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jinorgbio.2012.04.018PMID 22841366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.

  2012cited by this paper
• Progress in artificial metallonucleases.

  2012cited by this paper
• Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.

  2012cited by this paper
• DNA binding, prominent DNA cleavage and efficient anticancer activities of tris(diimine)iron(II) complexes.

  2011cited by this paper
• Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.

  2011cited by this paper
• Interaction of rac-[M(diimine)3]2+ (M=Co, Ni) complexes with CT DNA: role of 5,6-dmp ligand on DNA binding and cleavage and cytotoxicity.

  2011cited by this paper
• DNA molecular recognition and cellular selectivity of anticancer metal(II) complexes of ethylenediaminediacetate and phenanthroline: multiple targets

  2011cited by this paper
• Ferrocene-Promoted Photoactivated DNA Cleavage and Anticancer Activity of Terpyridyl Copper(II) Phenanthroline Complexes

  2010cited by this paper
• Photocytotoxic lanthanum(III) and gadolinium(III) complexes of phenanthroline bases showing light-induced DNA cleavage activity.

  2010cited by this paper
• Mononuclear Cu(II)-phenolate bioinspired complex is catalytically promiscuous: phosphodiester and peptide amide bond cleavage.

  2009cited by this paper
• Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.

  2009cited by this paper
• DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.

  2009cited by this paper
• Synthesis, characterization, DNA-binding study and anticancer properties of ternary metal(II) complexes of edda and an intercalating ligand.

  2008cited by this paper
• Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity.

  2008cited by this paper
• Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.

  2008cited by this paper
• Interaction of rac-[Cu(diimine)3]2+ and rac-[Zn(diimine)3]2+ complexes with CT DNA: effect of fluxional Cu(II) geometry on DNA binding, ligand-promoted exciton coupling and prominent DNA cleavage.

  2008cited by this paper
• Non-covalent DNA binding and cytotoxicity of certain mixed-ligand ruthenium(II) complexes of 2,2'-dipyridylamine and diimines.

  2008cited by this paper
• Hydrolytic cleavage of DNA by a ruthenium(II) polypyridyl complex.

  2007cited by this paper
• Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity.

  2007cited by this paper
• Non Platinum Metal Complexes as Anti‐cancer Drugs

  2007cited by this paper
• Ruthenium complexes can target determinants of tumour malignancy.

  2007cited by this paper
• Design of targeting ligands in medicinal inorganic chemistry.

  2006cited by this paper
• Synthesis, crystal structure, nuclease and in vitro antitumor activities of a new mononuclear copper(II) complex containing a tripodal N3O ligand

  2006cited by this paper
• Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy

  2006cited by this paper
• Cisplatin : chemistry and biochemistry of a leading anticancer drug

  2006cited by this paper
• The Discovery and Development of Cisplatin

  2006cited by this paper
• The square-planar cytotoxic [Cu(II)(pyrimol)Cl] complex acts as an efficient DNA cleaver without reductant.

  2006cited by this paper
• From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

  2006cited by this paper
• The Square-Planar Cytotoxic [CuII(pyrimol)Cl] Complex Acts as an Efficient DNA Cleaver without Reductant

  2006cited by this paper
• Changing selectivity of DNA oxidation from deoxyribose to Guanine by ligand design and a new binuclear copper complex.

  2005cited by this paper
• Mechanistic studies on DNA damage by minor groove binding copper–phenanthroline conjugates

  2005cited by this paper
• A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

  2004cited by this paper
• Functionalized Cyclopentadienyl Titanium Organometallic Compounds as New Antitumor Drugs

  2004cited by this paper
• Iron(III) complexes of sterically hindered tetradentate monophenolate ligands as functional models for catechol 1,2-dioxygenases: the role of ligand stereoelectronic properties.

  2004cited by this paper
• A novel cytotoxic ternary copper(II) complex of 1,10-phenanthroline and L-threonine with DNA nuclease activity.

  2004cited by this paper
• Dioxygen activation at a single copper site: structure, bonding, and mechanism of formation of 1:1 Cu-O2 adducts.

  2004cited by this paper
• Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L=o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]

  2004cited by this paper
• Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.

  2003cited by this paper
• DNA-binding and cleavage studies of macrocyclic copper(II) complexes.

  2002cited by this paper
• Intramolecular DNA coiling mediated by metallo-supramolecular cylinders: Differential binding of P and M helical enantiomers

  2002cited by this paper
• A simple, high-resolution method for establishing DNA binding affinity and sequence selectivity.

  2001cited by this paper
• Pharmacological Effects of the Ruthenium Complex NAMI-A Given Orally to CBA Mice With MCa Mammary Carcinoma

  2001cited by this paper
• Inhibition of cancer cell growth by ruthenium(II) arene complexes.

  2001cited by this paper
• Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice.

  2000cited by this paper
• Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.

  2000cited by this paper
• Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.

  1999cited by this paper
• Cellular pharmacology of polynuclear platinum anti-cancer agents.

  1999cited by this paper
• Metals in Medicine.

  1999cited by this paper
• Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumors.

  1999cited by this paper
• Medicinal Inorganic Chemistry

  1999cited by this paper
• Oxidation of CuII to CuIII, Free Radical Production, and DNA Cleavage by Hydroxy-salen−Copper Complexes. Isomeric Effects Studied by ESR and Electrochemistry

  1999cited by this paper
• A 1H NMR Study of the DNA Binding of Ruthenium(II) Polypyridyl Complexes

  1998cited by this paper
• Binuclear chloro-bridged palladated and platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxicity against cisplatin resistant tumor cell lines.

  1998cited by this paper
• Preparation of a spermine conjugate of the bis-phenanthroline ligand Clip-Phen and evaluation of the corresponding copper complex.

  1998cited by this paper
• Ni(II)·Xaa-Xaa-His Induced DNA Cleavage: Deoxyribose Modification by a Common “Activated” Intermediate Derived from KHSO5, MMPP, or H2O2

  1998cited by this paper
• Structural Studies of Λ- and Δ-[Ru(phen)2dppz]2+ Bound to d(GTCGAC)2: Characterization of Enantioselective Intercalation

  1997cited by this paper
• Structure/nuclease activity relationships of DNA cleavers based on cationic metalloporphyrin-oligonucleotide conjugates.

  1996cited by this paper
• In vitro evaluation of a p53‐expressing adenovirus as an anti‐cancer drug

  1996cited by this paper
• What Species Is Responsible for Strand Scission in the Reaction of [FeIIEDTA]2- and H2O2 with DNA?

  1995cited by this paper
• Facial co-ordination in bis[bis(benzimidazol-2-ylmethyl)-amine]copper(II) perchlorate dihydrate. Synthesis, structure, spectra and redox behaviour

  1995cited by this paper
• Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse

  1994cited by this paper
• Principles Of Bioinorganic Chemistry

  1994cited by this paper
• Cytotoxicity and antiviral activity of transition-metal salicylato complexes and crystal structure of Bis(diisopropylsalicylato)(1,10-phenanthroline)copper(II)

  1993cited by this paper
• Potassium monopersulfate and a water-soluble manganese porphyrin complex, [Mn(TMPyP)](OAc)5, as an efficient reagent for the oxidative cleavage of DNA.

  1989cited by this paper
• New Ruthenium Complexes for the Treatment of Cancer

  1989cited by this paper
• Unusual changes in hyperfine coupling constants observed for copper(II) complexes with N,N-bis(benzimidazol-2-ylmethyl)amine and its homologues; X-ray crystal structure determinations of [CuLPri(NO3)(MeOH)]NO3, [CuLBut(NO3)(MeOH)]NO3, [CuLBun(NO3)]NO3, and [CuLBui(NO3)]NO3

  1988cited by this paper
• Metal-activated hydrolytic cleavage of DNA

  1987cited by this paper
• Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen–sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2′-yl)-2,6-dithiaheptane]copper(II) perchlorate

  1984cited by this paper
• Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect.

  1984cited by this paper
• The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).

  1967cited by this paper
• A procedure for the isolation of deoxyribonucleic acid from micro-organisms

  1961cited by this paper
• A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid

  1954cited by this paper
• Buffers in the Range of pH 6.5 to 9.6.∗

  1946cited by this paper

• The crystal structure of chlorido-(2,4-dichloro-6-formylphenolato-κ2O,O′)-(2,2′-bipyridine-κ2N,N′)-copper(II), C17H11Cl3CuN2O2

  2026cites this paper
• Mixed ligand Cu(II)-curcumin complexes of diimine co-ligands: Hydrophobicity of 5,6-dmp demonstrates enhanced cytotoxicity with colon cancer cells

  2026cites this paper
• Synthesis, Structure, DNA/BSA Binding, DNA Cleaving, Cytotoxic and SOD Mimetic Activities of Copper(II) Complexes Derived from Methoxybenzylamine Schiff Base Ligands

  2025cites this paper
• Enhanced photoinduced antimicrobial properties of a copper(II) polypyridine naphthalene diimide complex for wound infection treatment and biomolecular interactions.

  2025cites this paper
• Synthesis and characterization of rare earth metal complexes with novel Schiff base

  2025cites this paper
• Structurally modified dipyrazinylpyridine-based homoleptic Cu(II) complexes: comparative cytotoxic evaluation in breast cancer cell lines.

  2025cites this paper
• Recent advances of Schiff base metal complexes as potential anticancer agents

  2025cites this paper
• Copper(ii) complexes based on 2-ferrocenyl-1,10-phenanthroline: structure, redox properties, cytotoxicity and apoptosis

  2025cites this paper
• Hydrazonate-Based Copper(II) Metallodrugs: Insights into Solution Behavior, G-Quadruplex DNA Interaction, and Anticancer Potential.

  2025cites this paper
• Copper(II) polypyridine complexes containing hydrazone/thioamide ligands as electrocatalysts for oxygen evolution reaction

  2025cites this paper
• Promising Dual Anticancer and Antimetastatic Action by a Cu(II) Complex Derived from Acylhydrazone on Human Osteosarcoma Models.

  2024cites this paper
• Metal-Based Drug–DNA Interactions and Analytical Determination Methods

  2024cites this paper
• DNA and albumin interaction studies of imidazole-based thiosemicarbazone-metal(II) chelates using spectroscopic and molecular docking methods: DNA cleavage, antioxidant and anti-inflammatory properties

  2023cites this paper
• In vitro biological and in silico screening of novel iron(iii) complexes for DNA-targeted antitumor drug component

  2023cites this paper
• Terpyridine-Containing 5-(2-Pyridylmethylene)-2-thioimidazolones and Their Coordination Compounds with Copper(II) Chloride: Synthesis and Cytotoxicity

  2023cites this paper
• Study of novel bidentate heterocyclic amine-based metal complexes and their biological activities: cytotoxicity and antimicrobial activity evaluation

  2023cites this paper
• Mixed ligand copper(II)-diimine complexes of 2-formylpyridine-N4-phenylthiosemicarbazone: diimine co-ligands tune the in vitro nanomolar cytotoxicity.

  2023cites this paper
• Copper(ii) complexes of the CuN4S core: selective cytotoxicity to cancerous cells, ROS generation and induction of apoptosis

  2023cites this paper
• Crystal structure of [2-({[2-(dimethylamino-κN)ethyl]imino-κN}methyl)phenolato-κO](1,10-phenanthroline-κ2 N,N′)copper(II) perchlorate

  2023cites this paper
• Non-Covalent Binding Studies of Transition Metal Complexes with DNA: A Review

  2023cites this paper
• Comparative DNA-/BSA-binding, DNA cleavage, and cytotoxic properties of copper(II) amino/ salicyl-phenolate Schiff bases (phen) complexes that induce generation of phenoxyl radicals

  2023cites this paper
• Promising Catalytic Activity of a Mononuclear Copper(II) Complex: Functional Mimic for Amine and Catechol Oxidases

  2023cites this paper
• DNA, a target of mixed chelate copper(II) compounds (Casiopeinas®) studied by electrophoresis, UV-vis and circular dichroism techniques.

  2022cites this paper
• Therapeutical potential of metal complexes of quinoxaline derivatives: a review

  2022cites this paper
• Cu(II), Mn(II) and Zn(II) Complexes of Anthracene‐Affixed Carboxylate‐Rich Tridentate Ligand: Synthesis, Structure, Spectroscopic Investigation and Their DNA Binding Profile

  2022cites this paper
• Syntheses, Structure, DNA Docking and Antimicrobial Studies of Copper(II) Complexes with Diethylenetriamine and N-Bidentate Ligands

  2022cites this paper
• Biological activity of mixed chelate copper(II) complexes, with substituted diimine and tridentate Schiff bases (NNO) and their hydrogenated derivatives as secondary ligands: Casiopeína's fourth generation.

  2022cites this paper
• Folic Acid-Conjugated Mixed-Ligand Copper(II) Complexes as Promising Cytotoxic Agents for Triple-Negative Breast Cancers: A Case Study Using MDA-MB-231 Cell

  2021cites this paper
• Phenoxy-imino ligands: coordination chemistry and binding properties with copper(II) cations

  2021cites this paper
• Synthesis, characterization, crystal structure, DNA and human serum albumin interactions, as well as antiproliferative activity of a Cu(II) complex containing a Schiff base ligand formed in situ from the Cu(II)‐induced cyclization of 1,5‐bis(salicylidene)thiocarbohydrazide

  2021cites this paper
• A novel single-pot synthesis of dinuclear and mononuclear copper(II) complexes with sterically demanding Schiff bases: Structural, spectral, magnetic, electrochemical, DNA binding and theoretical investigation

  2021cites this paper
• Copper(ii) complexes of 2-methyl-8-hydroxyquinoline and tri/diimine co-ligand: DFT calculations, DNA and BSA binding, DNA cleavage, cytotoxicity and induction of apoptosis

  2021cites this paper
• Antitumor activity of tridentate pincer and related metal complexes.

  2021cites this paper
• Potential of Metal Complexes for the Treatment of Cancer: Current Update and Future Prospective

  2021cites this paper
• Design, Synthesis, Bioanalytical, Photophysical and Chemo-phototherapeutic Studies of Heteroleptic Cu(II) Complexes

  2021cites this paper
• The tendency of the charge transfer system, derived from chloranilic acid and 2-amino-2-(hydroxymethyl)-1,3-propanediol towards copper(II) complex-formation: characterization, anion impact, and biological studies.

  2021cites this paper
• Mixed ligand copper(II) complexes of diimine co-ligands: Synthesis, characterization, DNA binding and DNA cleavage activity

  2021cites this paper
• Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres

  2021cites this paper
• Copper complexes as antitumor agents: in vitro and in vivo evidences.

  2021cites this paper
• Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on CuII/CuI redox, DNA binding and cleavage, cytotoxicity and apoptosis-inducing ability.

  2020cites this paper
• Folate-engineered mesoporous silica-encapsulated copper (II) complex [Cu(L)(dppz)]+: An active targeting cell-specific platform for breast cancer therapy

  2020cites this paper
• Nanometer‐sized, rod‐like, ligand‐containing tryptophan complexes: Anion influence–structural geometry–antitumor activity correlations

  2020cites this paper
• Mononuclear cobalt(II), nickel(II) and copper(II) complexes: Synthesis, spectral characterization and interaction study with nucleotide by in vitro biochemical analysis

  2020cites this paper
• Bis- and mixed-ligand copper(II) complexes of nalidixic acid the antibacterial drug: Mode of nalidixate coordination determines DNA binding and cleavage and cytotoxicity

  2020cites this paper
• Antiproliferative Activities of Diimine-based Mixed Ligand Copper(II) Complexes.

  2020cites this paper
• Ternary copper(II) complexes with 1,10‑phenanthroline and various aminoacidates: A spectroscopic and voltammetric study in aqueous solution.

  2019cites this paper
• Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres.

  2019cites this paper
• Copper(ii) complexes with 4-acyl pyrazolone derivatives and diimine coligands: synthesis, structural characterization, DNA binding and antitumor activity

  2019cites this paper
• Ternary Copper (II) complex based chemical probes for DNA targeting: Cytotoxic activity under visible light

  2019cites this paper
• Biological evaluation of copper(II) complex with nalidixic acid and 2,2′-bipyridine (bpy)

  2019cites this paper
• Ruthenium(II) carbonyl complexes containing thiourea ligand: Enhancing the biological assets through biomolecules interaction and enzyme mimetic activities

  2019cites this paper
• Functional models for type-2 and type-3 copper oxidases: Self-assembled molecular association in [Cu(L)(Hdpa)](ClO4) determines the catalytic activity

  2019cites this paper
• A new copper complex enhanced apoptosis in human breast cancerous cells without considerable effects on normal cells

  2019cites this paper
• New sulfonamide complexes with essential metal ions [Cu (II), Co (II), Ni (II) and Zn (II)]. Effect of the geometry and the metal ion on DNA binding and nuclease activity. BSA protein interaction.

  2019cites this paper
• Preparation, characterization and biological evaluation of two chiral binuclear copper(II) complexes

  2018cites this paper
• Functional mimics of type-2 and type-3 copper oxidases: Self-assembled molecular association in mononuclear copper(II) complex enhances the catalytic activity

  2018cites this paper
• Noble Metals in Pharmaceuticals: Applications and Limitations

  2018cites this paper
• The cytotoxicity effects of a novel Cu complex on MCF-7 human breast cancerous cells

  2018influential citation
• Copper(II) complexes of N3O tripodal ligands appended with pyrene and polyamine groups: Anti-proliferative and nuclease activities.

  2018cites this paper
• New binary copper(II) complexes containing intercalating ligands: DNA interactions, an unusual static quenching mechanism of BSA and cytotoxic activities

  2018cites this paper
• Crystal structure, optical properties, DFT analysis of new morpholine based Schiff base ligands and their copper(II) complexes: DNA, protein docking analyses, antibacterial study and anticancer evaluation.

  2018cites this paper
• Synthesis, spectral and single crystal X-ray characterization of 5-(2-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)hydrazono)pyrimidine-2,4,6(1H,3H,5H)-trione and its copper(II) complexes

  2018cites this paper
• Synthesis, characterization and biological investigations of novel Schiff base ligands containing imidazoline moiety and their Co(II) and Cu(II) complexes

  2018cites this paper
• DNA interaction, antimicrobial, antioxidant and anticancer studies on Cu(II) complexes of Luotonin A.

  2017cites this paper
• DNA interaction and cleavage studies of ancillary chiral ligand and N,N-donor ligands coordinated platinum(II) complexes

  2017cites this paper
• Ruthenium(II/III) complexes of redox non-innocent bis(thiosemicarbazone) ligands: Synthesis, X-ray crystal structures, electrochemical, DNA binding and DFT studies

  2017cites this paper
• Synthesis, crystal structures, DNA/bovine serum albumin binding, DNA cleavage and cytotoxicity of five mononuclear zinc(II) complexes

  2017cites this paper
• Highly efficient and facile fabrication of monodispersed Au nanoparticles using pullulan and their application as anticancer drug carriers.

  2017cites this paper
• Synthesis and structural characterization of a vanadium(V)-pyridylbenzimidazole complex: DNA binding and anticancer activity

  2017cites this paper
• DNA and protein binding, double-strand DNA cleavage and cytotoxicity of mixed ligand copper(II) complexes of the antibacterial drug nalidixic acid.

  2017cites this paper
• Synthesis, Characterization and Biological Activities of Biopolymeric Schiff Bases Prepared with Chitosan and Salicylaldehydes and Their Pd(II) and Pt(II) Complexes

  2017cites this paper
• Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.

  2017cites this paper
• DNA/BSA binding ability and genotoxic effect of mono- and binuclear copper (II) complexes containing a Schiff base derived from salicylaldehyde and D, L-glutamic acid

  2017cites this paper
• Cu(II) complexes with 4-amino-3,5-dimethyl isoxazole and substituted aromatic aldehyde Schiff bases: synthesis, crystal structure, antimicrobial activity, DNA binding and cleavage studies

  2017cites this paper
• New cobalt(II) and nickel(II) complexes of benzyl carbazate Schiff bases: Syntheses, crystal structures, in vitro DNA and HSA binding studies.

  2016cites this paper
• Ni(ii)/Cu(ii)/Zn(ii) 5,5-diethylbarbiturate complexes with 1,10-phenanthroline and 2,2'-dipyridylamine: synthesis, structures, DNA/BSA binding, nuclease activity, molecular docking, cellular uptake, cytotoxicity and the mode of cell death.

  2016cites this paper
• Synthesis, characterization and biological studies on NiII and CuII complexes of two novel α,β-unsaturated 1,3-diketones related to curcuminoids

  2016cites this paper
• Oxidative DNA Cleavage Promoted by a Phenoxyl‐Radical Copper(II) Complex

  2016cites this paper
• Synthesis, DNA-binding, and cytotoxic studies on three copper(II) complexes of unsymmetrical synthetic analogues of curcumin

  2016cites this paper
• Exploration of biological activities of alkyne arms containing Cu( ii ) and Ni( ii ) complexes: syntheses, crystal structures and DFT calculations

  2016cites this paper
• Toward a new avenue in ruthenium-sulphur chemistry of binuclear μ -sulphido bridged ( μ -S) 2 complexes having Ru 2 S 2 core: Targeted synthesis, crystal structure, biomolecules interaction and their in vitro anticancer activities

  2016cites this paper
• Binuclear Cu(II) Schiff base complexes as prescursors for the synthesis of CuO nanoparticles: anticancer activity against MCF-7 cell line

  2016cites this paper
• DNA CLEAVAGE ACTIVITY OF NOVEL SCHIFF BASE COPPER(II) COMPLEXES WITH SULFUR CONTAINING-LIGANDS: (2-(2-METHYLTHIO)PHENYLIMINO)METHYLPHENOL, N-BENZYLIDINE-2-METHYLTHIOANILINE

  2016cites this paper
• Novel mononuclear ruthenium(II) complexes as potent and low-toxicity antitumour agents: synthesis, characterization, biological evaluation and mechanism of action

  2016cites this paper
• Biological evaluation of redox stable cisplatin/Cu(II)-DNA adducts as potential anticancer agents

  2016cites this paper
• In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes.

  2015cites this paper
• Synthesis, characterization, crystal structure and cytotoxic properties of thiosemicarbazide Ni(II) and Zn(II) complexes.

  2015cites this paper
• Surfactant–copper(II) Schiff base complexes: synthesis, structural investigation, DNA interaction, docking studies, and cytotoxic activity

  2015cites this paper
• In vitro antiproliferative and apoptosis-inducing properties of a mononuclear copper(II) complex with dppz ligand, in two genotypically different breast cancer cell lines

  2015cites this paper
• Ligand centered radical pathway in catechol oxidase activity with a trinuclear zinc-based model: synthesis, structural characterization and luminescence properties.

  2015cites this paper
• Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.

  2015cites this paper
• Five water-soluble zwitterionic copper(II)-carboxylate polymers: role of dipyridyl coligands in enhancing the DNA-binding, cleaving and anticancer activities.

  2015cites this paper
• Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers.

  2015cites this paper
• Crystal structure of catena-poly[[chlorido(4,4′-dimethyl-2,2′-bipyridine-κ2 N,N′)copper(II)]-μ-chlorido]

  2015cites this paper
• In Vitro Antitumor Activity of a Keggin Vanadium-Substituted Polyoxomolybdate and Its ctDNA Binding Properties

  2015cites this paper
• Assessment of a novel Cu (II) complex as a potential anticancer agent

  2015cites this paper
• COPPER(II) COMPLEXES AS IN VITRO ANTICANCER AGENTS AGAINST HUMAN BREAST CANCER MCF-7 CELL LINE: A REVIEW

  2015cites this paper
• Water soluble copper(II) complex [Cu(dipica)(CH 3 COO)]ClO 4 : DNA binding, pH dependent DNA cleavage and cytotoxicity

  2015cites this paper
• A novel cationic copper(II) Schiff base complex: Synthesis, characterization, crystal structure, electrochemical evaluation, anti-cancer activity, and preparation of its metal oxide nanoparticles

  2015cites this paper
• Synthesis and characterization of cobalt(II), nickel(II) and copper(II)-based potential photosensitizers: Evaluation of their DNA binding profile, cleavage and photocytotoxicity

  2015cites this paper